Observations placeholder
Cimzia
Identifier
018206
Type of Spiritual Experience
Number of hallucinations: 12
Background
A description of the experience
Certolizumab pegol (CDP870, tradename Cimzia) is a monoclonal antibody to tumor necrosis factor alpha (TNF-α), for the treatment of Crohn's disease and rheumatoid arthritis,
On Dec, 03, 2016 23,631 people reported to have side effects when taking Cimzia.
Among them, 12 people (0.05%) have Hallucination
Time on Cimzia when people have Hallucination :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Hallucination0.00%50.00%0.00%0.00%50.00%0.00%0.00%
On Oct, 8, 2015: 12,969 people reported to have side effects when taking Cimzia. Among them, 79 people (0.61%) have Death.
Time on Cimzia when people have Death :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Death40.62%37.50%6.25%12.50%3.12%0.00%0.00%